Glaxosmithkline (GSK)

 

GSK Share PerformanceMore

52 week high1,745.5 11/10/16
52 week low1,314.5 10/02/16
52 week change 217.0 (15.91%)
4 week volume123,840,694 21/12/16

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Director/PDMR Shareholding

RNS Number: 2974U GlaxoSmithKline PLC 16 January 2017 GlaxoSmithKline plc (the ' Company ') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Sir Andrew Witty b) Position/status Chief Executive Officer c) Initial notification/ amendment Initial notification 2. Details of the issuer, emission allowance market partic...

Director/PDMR Shareholding

RNS Number: 2966U GlaxoSmithKline PLC 16 January 2017 GlaxoSmithKline plc (the ' Company ') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Sir Andrew Witty b) Position/status Chief Executive Officer c) Initial notification/ amendment Initial notification 2. Details of the issuer, emission allowance market partic...

Director Deals - GlaxoSmithKline PLC (GSK)

Dr Moncef Slaoui, Executive Director, has re-invested 1,694 shares in the company on the 12th January 2017 at a price of 15...

Director Deals - GlaxoSmithKline PLC (GSK)

Simon Dingemans, Financial Director, has re-invested 122 shares in the company on the 12th January 2017 at a price of 157...

Director Deals - GlaxoSmithKline PLC (GSK)

Emma Walmsley, Executive Director, has re-invested 489 shares in the company on the 12th January 2017 at a price of 157...

Director Deals - GlaxoSmithKline PLC (GSK)

Dr Patrick Vallance, Executive Director, has re-invested 245 shares in the company on the 12th January 2017 at a price of 1...

Director/PDMR Shareholding

RNS Number: 2918U GlaxoSmithKline PLC 16 January 2017 GlaxoSmithKline plc (the ' Company ') Transaction Notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Ms C Thomas b) Position/status SVP, HR c) Initial notification/ amendment Initial notification 2. Details of the issuer, emission allowance market participant, auction platf...

Director/PDMR Shareholding

RNS Number: 2908U GlaxoSmithKline PLC 16 January 2017 GlaxoSmithKline plc (the ' Company ') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Dr M M Slaoui b) Position/status Chairman, Global Vaccines c) Initial notification/ amendment Initial notification 2. Details of the issuer, emission allowance market partic...

Fundamental DataMore

P/E ratio9.068
EPS174.3
Dividend yield5.062 %

Latest discussion posts More

  • Re: Woodford article

    Many thanks for your expert's salutary warning about stock market databases, aspace. I never dreamt before about questioning them. Shock market, more like.
    15-Jan-2017
    budu
  • Re: Woodford article

    aspace - a couple of observations, perhaps of some relevance: "... the above net cash flows of around #5 billion per annum don?t inspire me to buy into a market ...
    14-Jan-2017
    Bill1703
  • Re: Woodford article

    Thanks for your comments and challenges to my analysis, which forced me to reconsider whether I had been too pessimistic. Responding to each: Broncomaniac, As you point ...
    14-Jan-2017
    aspace

Users' HoldingsMore

Users who hold Glaxosmithkline also hold..
VODAFONE GRP.35%
BP34%
NATIONAL GRID32%
RDS 'B'31%
LLOYDS GRP.29%

Codes & Symbols

ISINGB0009252882
SymbolsGSK, LSE:GSK, GSK.L, GSK:LN, LON:GSK, XLON:GSK